Study to Characterize the Pharmacokinetics of Raltegravir in the Gastrointestinal (GI) Tract of Healthy Male Volunteers

NCT01325051 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: Raltegravir

Sponsor

Angela Kashuba, PharmD

Collaborators

[object Object]